Resumes
Resumes
Yingyun Wu Phones & Addresses
-
Frederick, MD
-
23838 Burdette Forest Rd, Clarksburg, MD 20871
-
Rockville, MD
-
Gaithersburg, MD
-
Boone, NC
-
College Station, TX
Publications
Us Patents
Modified Rsv F Proteins And Methods Of Their Use
View pageUS Patent:
20100239617, Sep 23, 2010
Filed:
Dec 9, 2009
Appl. No.:
12/633995
Inventors:
Peter PUSHKO - Frederick MD, US
Yingyun Wu - Gaithersburg MD, US
Michael Massare - Mt. Airy MD, US
Ye Liu - Laurel MD, US
Gale Smith - Gaithersburg MD, US
Bin Zhou - Gaithersburg MD, US
Yingyun Wu - Gaithersburg MD, US
Michael Massare - Mt. Airy MD, US
Ye Liu - Laurel MD, US
Gale Smith - Gaithersburg MD, US
Bin Zhou - Gaithersburg MD, US
International Classification:
A61K 39/155
C07K 14/135
C07H 21/02
C12N 5/10
C12N 7/00
A61K 9/00
A61P 31/14
C07K 14/135
C07H 21/02
C12N 5/10
C12N 7/00
A61K 9/00
A61P 31/14
US Classification:
424400, 530350, 536 234, 435348, 4241861, 4352351
Abstract:
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
Highly Efficient Influenza Matrix (M1) Proteins
View pageUS Patent:
20130039938, Feb 14, 2013
Filed:
Oct 24, 2011
Appl. No.:
13/280043
Inventors:
Gale SMITH - Gaithersburg MD, US
Yingyun Wu - Clarksburg MD, US
Michael Massare - Mt. Airy MD, US
Peter Pushko - Frederick MD, US
Margret Nathan - Montgomery Village MD, US
Thomas Kort - Germantown MD, US
Robin Robinson - Rockville MD, US
Yingyun Wu - Clarksburg MD, US
Michael Massare - Mt. Airy MD, US
Peter Pushko - Frederick MD, US
Margret Nathan - Montgomery Village MD, US
Thomas Kort - Germantown MD, US
Robin Robinson - Rockville MD, US
Assignee:
NOVAVAX, INC. - Rockville MD
International Classification:
A61K 39/145
C12P 21/02
C12N 9/24
C07K 14/11
A61P 37/04
C12P 21/02
C12N 9/24
C07K 14/11
A61P 37/04
US Classification:
4241921, 530350, 4242101, 4242091, 435200, 435 691
Abstract:
This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus
View pageUS Patent:
20130122032, May 16, 2013
Filed:
Sep 27, 2012
Appl. No.:
13/629107
Inventors:
Gale SMITH - Rockville MD, US
Yingyun Wu - Rockville MD, US
Michael Massare - Rockville MD, US
Ye Liu - Rockville MD, US
Yingyun Wu - Rockville MD, US
Michael Massare - Rockville MD, US
Ye Liu - Rockville MD, US
International Classification:
C07K 14/135
A61K 39/155
A61K 39/155
US Classification:
4241861
Abstract:
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
Respiratory Syncytial Virus-Virus Like Particle (Vlps)
View pageUS Patent:
20080233150, Sep 25, 2008
Filed:
Nov 16, 2007
Appl. No.:
11/941768
Inventors:
Gale SMITH - Rockville MD, US
Peter Pushko - Rockville MD, US
Mike Massare - Rockville MD, US
Yingyun Wu - Rockville MD, US
Kutub Mahmood - Rockville MD, US
Peter Pushko - Rockville MD, US
Mike Massare - Rockville MD, US
Yingyun Wu - Rockville MD, US
Kutub Mahmood - Rockville MD, US
International Classification:
A61K 39/155
A61P 31/12
C07K 16/00
A61P 31/12
C07K 16/00
US Classification:
4242111, 5303873
Abstract:
The present invention discloses and claims virus like particles (VLPs) that express and/or contains RSV proteins. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing immunity to infections, including RSV.
Modified Rsv F Proteins And Methods Of Their Use
View pageUS Patent:
20200030436, Jan 30, 2020
Filed:
Oct 11, 2019
Appl. No.:
16/599568
Inventors:
- Gaithersburg MD, US
Yingyun WU - Clarksburg MD, US
Michael J. MASSARE - Mt. Airy MD, US
Ye LIU - Clarksville MD, US
Gale SMITH - Germantown MD, US
Bin ZHOU - Clarksburg MD, US
Yingyun WU - Clarksburg MD, US
Michael J. MASSARE - Mt. Airy MD, US
Ye LIU - Clarksville MD, US
Gale SMITH - Germantown MD, US
Bin ZHOU - Clarksburg MD, US
International Classification:
A61K 39/155
A61K 39/12
C07K 14/005
C12N 7/00
A61K 9/00
A61K 39/39
A61K 9/107
A61K 39/12
C07K 14/005
C12N 7/00
A61K 9/00
A61K 39/39
A61K 9/107
Abstract:
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
Highly Efficient Influenza Matrix (M1) Proteins
View pageUS Patent:
20190062713, Feb 28, 2019
Filed:
Mar 22, 2018
Appl. No.:
15/928385
Inventors:
- Gaithersburg MD, US
Yingyun WU - Clarksburg MD, US
Michael J. MASSARE - Mt. Airy MD, US
Peter M. PUSHKO - Frederick MD, US
Margaret NATHAN - Montgomery Village MD, US
Thomas KORT - Germantown MD, US
Robin ROBINSON - Dickerson MD, US
Yingyun WU - Clarksburg MD, US
Michael J. MASSARE - Mt. Airy MD, US
Peter M. PUSHKO - Frederick MD, US
Margaret NATHAN - Montgomery Village MD, US
Thomas KORT - Germantown MD, US
Robin ROBINSON - Dickerson MD, US
International Classification:
C12N 7/00
A61K 39/12
C12N 9/24
A61K 39/12
C12N 9/24
Abstract:
This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.
Recombinant Nanoparticle Rsv F Vaccine For Respiratory Syncytial Virus
View pageUS Patent:
20170319682, Nov 9, 2017
Filed:
Feb 15, 2017
Appl. No.:
15/433759
Inventors:
- Gaithersburg MD, US
Yingyun WU - Gaithersburg MD, US
Michael MASSARE - Gaithersburg MD, US
Ye LIU - Gaithersburg MD, US
Yingyun WU - Gaithersburg MD, US
Michael MASSARE - Gaithersburg MD, US
Ye LIU - Gaithersburg MD, US
International Classification:
A61K 39/155
A61K 39/12
C07K 14/135
C07K 14/005
C12N 7/00
A61K 39/00
A61K 39/00
A61K 39/00
A61K 39/00
A61K 39/12
C07K 14/135
C07K 14/005
C12N 7/00
A61K 39/00
A61K 39/00
A61K 39/00
A61K 39/00
Abstract:
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
Highly Efficient Influenza Matrix (M1) Proteins
View pageUS Patent:
20170253861, Sep 7, 2017
Filed:
Oct 6, 2016
Appl. No.:
15/287433
Inventors:
- Gaithersburg MD, US
Yingyun WU - Clarksburg MD, US
Michael J. MASSARE - Mt. Airy MD, US
Peter M. PUSHKO - Frederick MD, US
Margaret NATHAN - Montgomery Village MD, US
Thomas KORT - Germantown MD, US
Robin ROBINSON - Gaithersburg MD, US
Yingyun WU - Clarksburg MD, US
Michael J. MASSARE - Mt. Airy MD, US
Peter M. PUSHKO - Frederick MD, US
Margaret NATHAN - Montgomery Village MD, US
Thomas KORT - Germantown MD, US
Robin ROBINSON - Gaithersburg MD, US
International Classification:
A61K 39/12
C12N 7/00
A61K 39/145
C12N 15/86
C12N 7/00
A61K 39/145
C12N 15/86
Abstract:
This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.